Ibogaine for the treatment of Parkinson's disease: A case report

Erny, Tobias, Cano Montenegro, Elba Yatziri, Barth, Joern, Noller, Geoff · 2025 · Journal of Psychedelic Studies

AI-extracted · unverified · confirm at source

First validated-instrument case study of ibogaine for Parkinson's; 80-day low-dose treatment (25-75mg/day) showed improvements in UPDRS, PDQ-39, fatigue, depression; patient reported reduced freezing episodes and enhanced mobility

Dosing: 25–75 mg/day low-dose for 80 days (oral)

Sample size: 1